ReviewClinical & experimental metastasis2010
Leptomeningeal metastases from prostate cancer: an emerging clinical conundrum.
Review in Clinical & experimental metastasis, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 26 citations in OpenAlex.
- Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.Journal of neuro-oncology · 2014Trial
- Extra-axial small cell prostate carcinoma intracranial metastasis: illustrative case.Journal of neurosurgery. Case lessons · 2025Article
- Leptomeningeal metastases in prostate cancer: A review of the current literature.Current urology · 2024Article
- A case report of prostate cancer with leptomeningeal metastasis and bone marrow involvement.Cancer reports (Hoboken, N.J.) · 2024Article
- Visual loss as the initial manifestation of an ignored disseminated prostate cancer: A case report.American journal of ophthalmology case reports · 2022Article
- A case report of prostate cancer with leptomeningeal metastasis.Cancer reports (Hoboken, N.J.) · 2022Article
- A case report of prostate adenocarcinoma with leptomeningeal carcinomatosis and intracerebral metastasis.Clinical case reports · 2021Article
- Leptomeningeal Carcinomatosis of Prostate Cancer: A Case Report and Review of the Literature.Reviews in urology · 2020Article
- Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer.Case reports in urology · 2020Article
- Malignant invasion of the central nervous system: the hidden face of a poorly understood outcome of prostate cancer.World journal of urology · 2018Review
- Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report.Melanoma research · 2013Article
- Leptomeningeal metastases from genitourinary cancer: the University of Texas MD Anderson Cancer Center experience.Medical oncology (Northwood, London, England) · 2013Article
- Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.Surgical neurology international · 2013Article
- Durable remission of leptomeningeal metastases from hormone-responsive prostate cancer.Medical oncology (Northwood, London, England) · 2012Article
- Biology and therapy of neoplastic meningitis.Current oncology reports · 2010Review
- Rare Paravertebral and Skull Base Metastases in Prostate Cancer.Case reports in oncologyArticle
- A Case of Leptomeningeal Carcinomatosis from Aggressive Metastatic Prostate Cancer.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leptomeningeal metastases from solid tumors are relatively uncommon events with dismal prognosis. They can be seen mainly in patients with breast and lung cancer, and malignant melanoma, but have also been described in a variety of other tumor types. Leptomeningeal carcinomatosis from prostate cancer is an extremely rare complication, but as patients' survival is prolonged due to more effective treatments, it is expected that more patients will present with leptomeningeal involvement in advanced stages of the disease. In these cases high levels of prostate-specific antigen can be found in the cerebrospinal fluid. This comprehensive review presents the recent findings from the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.